Copyright
©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 111354
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.111354
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.111354
Figure 1 Phase implementation of artificial intelligence in metabolic dysfunction-associated steatotic liver disease care roadmap.
AI: Artificial intelligence; MASLD: Metabolic dysfunction-associated steatotic liver disease.
- Citation: Hegazy MAE. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Machine learning for non-invasive diagnosis and risk stratification. World J Hepatol 2025; 17(11): 111354
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/111354.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.111354
